These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17098332)

  • 1. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Hellström-Lindahl E; Ravid R; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.
    Russo R; Borghi R; Markesbery W; Tabaton M; Piccini A
    FEBS Lett; 2005 Nov; 579(27):6027-30. PubMed ID: 16226260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
    Iwata N; Takaki Y; Fukami S; Tsubuki S; Saido TC
    J Neurosci Res; 2002 Nov; 70(3):493-500. PubMed ID: 12391610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
    Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
    J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
    Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.
    Wang J; Dickson DW; Trojanowski JQ; Lee VM
    Exp Neurol; 1999 Aug; 158(2):328-37. PubMed ID: 10415140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
    Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
    Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta-amyloidogenesis].
    Ihara Y
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1100-1. PubMed ID: 9577656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.
    Funato H; Yoshimura M; Kusui K; Tamaoka A; Ishikawa K; Ohkoshi N; Namekata K; Okeda R; Ihara Y
    Am J Pathol; 1998 Jun; 152(6):1633-40. PubMed ID: 9626067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.
    Kalaria RN; Andorn AC; Harik SI
    Prog Clin Biol Res; 1989; 317():367-74. PubMed ID: 2557637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E; Saido TC
    Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques.
    Fukumoto H; Asami-Odaka A; Suzuki N; Shimada H; Ihara Y; Iwatsubo T
    Am J Pathol; 1996 Jan; 148(1):259-65. PubMed ID: 8546214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary distributions of amyloid-beta and neprilysin in the brains of dogs and cats.
    Takeuchi Y; Uetsuka K; Murayama M; Kikuta F; Takashima A; Doi K; Nakayama H
    Vet Pathol; 2008 Jul; 45(4):455-66. PubMed ID: 18587091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin and Alzheimer's disease.
    Burgos-Ramos E; Hervás-Aguilar A; Aguado-Llera D; Puebla-Jiménez L; Hernández-Pinto AM; Barrios V; Arilla-Ferreiro E
    Mol Cell Endocrinol; 2008 May; 286(1-2):104-11. PubMed ID: 18359553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.